» Articles » PMID: 8188664

Negative Feedback Regulation of Human Platelets Via Autocrine Activation of the Platelet-derived Growth Factor Alpha-receptor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1994 May 13
PMID 8188664
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Human platelets contain platelet-derived growth factor (PDGF) in their alpha-granules which is released during platelet exocytosis. We show by immunoprecipitation and 125I-PDGF binding experiments that human platelets have functionally active PDGF alpha-receptors, but not beta-receptors. The PDGF alpha-receptor (PDGFR-alpha) was identified as a 170-kDa glycosylated protein-tyrosine kinase as found in other cell types. Stimulation of platelets with 0.1 unit/ml thrombin resulted in a significant increase (2-5-fold) of the tyrosine phosphorylation of the PDGFR-alpha, as determined by immunoprecipitation with phosphotyrosine antiserum as well as with PDGFR-alpha antiserum. The observed thrombin-induced autophosphorylation of the PDGFR-alpha was inhibited by the addition of a neutralizing monoclonal PDGF antibody. Thus, our results suggest that the platelet PDGFR-alpha is stimulated in an autocrine manner by PDGF secreted during platelet activation. Preincubation of platelets with PDGF inhibited thrombin-induced platelet aggregation and secretion of ATP + ADP and beta-hexosaminidase. Thrombin-induced platelet aggregation was also reversed when PDGF was added 30 s after thrombin stimulation. Inhibition of the autocrine PDGF pathway during platelet activation by the PDGF antibody led to a potentiation of thrombin-induced beta-hexosaminidase secretion. Thus, the PDGFR-alpha takes part in a negative feedback regulation during platelet activation. Our demonstration of PDGF alpha-receptors on human platelets and its inhibitory function during platelet activation identifies a new possible role of PDGF in the regulation of thrombosis.

Citing Articles

Roles of PDGF/PDGFR signaling in various organs.

Jung S, Kang D, Ko E Korean J Physiol Pharmacol. 2024; 29(2):139-155.

PMID: 39482238 PMC: 11842291. DOI: 10.4196/kjpp.24.309.


Association between Gene Polymorphisms and Platelet-Rich Plasma's Efficiency in Treating Lateral Elbow Tendinopathy-A Prospective Cohort Study.

Jarosz A, Balcerzyk-Matic A, Iwanicka J, Iwanicki T, Nowak T, Szyluk K Int J Mol Sci. 2024; 25(8).

PMID: 38673853 PMC: 11050239. DOI: 10.3390/ijms25084266.


Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa.

Assi A, Farhat M, Hachem M, Zalaquett Z, Aoun M, Daher M J Bone Oncol. 2023; 43:100511.

PMID: 38058514 PMC: 10696463. DOI: 10.1016/j.jbo.2023.100511.


Platelet-rich plasma's (PRP) impacts on accelerated canine movement.

Le L, Do T, Truong N, Le P J Orthod Sci. 2023; 12:58.

PMID: 37881667 PMC: 10597380. DOI: 10.4103/jos.jos_1_23.


Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.

Zheng T, Parra-Izquierdo I, Reitsma S, Heinrich M, Larson M, Shatzel J Am J Physiol Cell Physiol. 2022; 323(4):C1231-C1250.

PMID: 35938677 PMC: 9576167. DOI: 10.1152/ajpcell.00040.2022.